# Continuous Glucose Monitoring Following Hospital Discharge

Study · id `cardio:ct-nct05360056` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05360056](<https://clinicaltrials.gov/study/NCT05360056>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05360056

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 108 participants.

## Technical summary

Registry record NCT05360056. Allocation not applicable; no masking; primary purpose treatment. Start 2022-04-26 (actual); primary completion 2024-08-31 (actual). Results posted on 2025-12-09.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 108 participants (enrolled count; ClinicalTrials.gov record NCT05360056, source copy `cardio:ctgov-nct05360056-2026-07-21`, retrieved 2026-10-26)
- Started: 2022-04-26 (actual) (ClinicalTrials.gov record NCT05360056, source copy `cardio:ctgov-nct05360056-2026-07-21`, retrieved 2026-10-26)
- Primary completion: 2024-08-31 (actual) (ClinicalTrials.gov record NCT05360056, source copy `cardio:ctgov-nct05360056-2026-07-21`, retrieved 2026-10-26)
- Completion: 2027-01 (anticipated) (ClinicalTrials.gov record NCT05360056, source copy `cardio:ctgov-nct05360056-2026-07-21`, retrieved 2026-10-26)
- Results first posted: 2025-12-09 (ClinicalTrials.gov record NCT05360056, source copy `cardio:ctgov-nct05360056-2026-07-21`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT05360056, source copy `cardio:ctgov-nct05360056-2026-07-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05360056-2026-07-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: Continuous Glucose Monitoring Following Hospital Discharge
- Condition: Type 2 Diabetes
- Intervention (Device): DexCom G6
- Lead sponsor: Kathleen Dungan
- Lead sponsor class: OTHER
- Collaborator: DexCom, Inc.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as a collaborator: DexCom, Inc. (`cardio:org-dexcom-inc`)

## Provenance

Content hash: e6710844e8eeb5a88c29d346a30d2db2aa430a31ddf69c823c2eb55d86d465ab
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
